Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
The Journal of Infectious Diseases
|
August 7, 1999
Phenotypic changes in drug susceptibility associated with failure of human immunodeficiency virus type 1 (HIV-1) triple combination therapy
N T Parkin, Y S Lie, N Hellmann, et al.
Nature
|
May 18, 1995
HIV results in the frame. Results confirmed
M A Nowak, S Bonhoeffer, C Loveday, et al.
Clinical and Experimental Immunology
|
August 24, 2004
CCTTT-repeat polymorphism of the inducible nitric oxide synthase is not associated with HIV pathogenesis
M Hersberger, S Bonhoeffer, S K Rampini, et al.
Journal of Virology
|
November 17, 2001
Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection
M R Betts, D R Ambrozak, D C Douek, et al.
Immunology Letters
|
April 15, 1999
Molecular tracking of an Human Immunodeficiency Virus nef specific cytotoxic T-cell clone shows persistence of clone-specific T-cell receptor DNA but not mRNA following early combination antiretroviral therapy
D F Nixon, D Douek, P J Kuebler, et al.
Lancet (London, England)
|
November 30, 1999
Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis
B Ramratnam, S Bonhoeffer, J Binley, et al.
Virology
|
April 25, 2000
Passive infusion of immune serum into simian immunodeficiency virus-infected rhesus macaques undergoing a rapid disease course has minimal effect on plasma viremia
J M Binley, B Clas, A Gettie, et al.
Nature
|
January 12, 1995
Viral dynamics in human immunodeficiency virus type 1 infection
X Wei, S K Ghosh, M E Taylor, et al.
The Journal of Experimental Medicine
|
July 22, 1998
HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy
L Morris, J M Binley, B A Clas, et al.
Molecular Medicine (Cambridge, Mass.)
|
November 9, 2000
An antigenic threshold for maintaining human immunodeficiency virus type 1-specific cytotoxic T lymphocytes
X Jin, G Ogg, S Bonhoeffer, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
The Journal of Infectious Diseases
|
August 7, 1999
Phenotypic changes in drug susceptibility associated with failure of human immunodeficiency virus type 1 (HIV-1) triple combination therapy
N T Parkin, Y S Lie, N Hellmann, et al.
Nature
|
May 18, 1995
HIV results in the frame. Results confirmed
M A Nowak, S Bonhoeffer, C Loveday, et al.
Clinical and Experimental Immunology
|
August 24, 2004
CCTTT-repeat polymorphism of the inducible nitric oxide synthase is not associated with HIV pathogenesis
M Hersberger, S Bonhoeffer, S K Rampini, et al.
Journal of Virology
|
November 17, 2001
Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection
M R Betts, D R Ambrozak, D C Douek, et al.
Immunology Letters
|
April 15, 1999
Molecular tracking of an Human Immunodeficiency Virus nef specific cytotoxic T-cell clone shows persistence of clone-specific T-cell receptor DNA but not mRNA following early combination antiretroviral therapy
D F Nixon, D Douek, P J Kuebler, et al.
Lancet (London, England)
|
November 30, 1999
Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis
B Ramratnam, S Bonhoeffer, J Binley, et al.
Virology
|
April 25, 2000
Passive infusion of immune serum into simian immunodeficiency virus-infected rhesus macaques undergoing a rapid disease course has minimal effect on plasma viremia
J M Binley, B Clas, A Gettie, et al.
Nature
|
January 12, 1995
Viral dynamics in human immunodeficiency virus type 1 infection
X Wei, S K Ghosh, M E Taylor, et al.
The Journal of Experimental Medicine
|
July 22, 1998
HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy
L Morris, J M Binley, B A Clas, et al.
Molecular Medicine (Cambridge, Mass.)
|
November 9, 2000
An antigenic threshold for maintaining human immunodeficiency virus type 1-specific cytotoxic T lymphocytes
X Jin, G Ogg, S Bonhoeffer, et al.
Page
of 5